"SNiP Technique" now used
in every major U.S.
hospital–could make
early investors 1,500%
It's not a drug or a pill, but rather a radical new FDA-approved technology, which could lower your blood pressure, save your eyesight, and even prevent Alzheimer's.
• The Economist says it "will revolutionize the entire health-care system." • Dr. Francis Collins of the National Institutes of Health (NIH) calls it a "historic movement... a revolution." • Dr. Dietrich Stephan exclaimed in The Wall Street Journal: "Oh my God, it's unbelievable — the air is crackling. Every day I hear rumors about studies coming out." Already, this technological breakthrough has brought some investors returns of more than 1,500%. The biggest gains are still to come...
Dear Reader,
A revolutionary medical technology is sweeping America's hospitals.
It's called the "SNiP Technique," and it's neither a drug or a pill.
Instead, it's a brand-new medical technology—perfected over the past 30 years at hospitals like the Mayo and Cleveland Clinics... the best medical schools (such as Harvard and Duke), and the richest health care companies (like Johnson & Johnson and Roche Diagnostics).
After 30 years of testing and study, the "SNiP Technique" is rolling out to commercial markets. It's already approved by the FDA, and is being used in some form in every major hospital in America.
That's why BusinessWeek says, this "new approach will eventually transform medicine."
I know that's a bold claim. But look at the effect it's already having right now across the entire country...
| • | Scientists at a Cambridge, Mass. healthcare firm are using the "SNiP Technique" to treat cancer. "We are going to change the diagnosis of cancer—and change the practice of medicine," proclaims Division President Kenneth Conway. |
| • | At the Univ. of Cal. San Francisco Cardiovascular Research Institute, doctors are using the "SNiP Technique" to treat heart disease. Says Associate Director John P. Kane: "We're embarking onto the open sea... and we're discovering things that nobody knew about." |
| • | And as patient Darlene Nipper said after the "SNiP Technique" cured her cancer: "This feels like a more civilized way of being treated." That's because, as David Baltimore (President of Cal Tech) recently told Time Magazine, "It will be a different kind of medicine." |
Obviously, a medical breakthrough this big is worth a lot of money. That's why—already—several companies involved have shot up 1,943%... 1,054%... and 2,315%, in as little as 6 months.
But even more exciting, from a financial perspective, is this:
Because this technology is so new, very few investors know about it right now. I only found out about it recently because of a scientist and a PhD chemist I hired from Johns Hopkins University.
What these guys told me is amazing...
A few simple investments today could realistically give you the chance to make 20-times your money (or more) over the next 24-36 months.
Let me explain everything I've learned, so you can decide if this is something worth taking advantage of...
"You only have 6 months to live"
It's not hard to see why this new technology should soon be worth a fortune.
Just consider the case of 50-year-old Meredith Dawson, from Atlanta...
As part of a routine checkup, Dawson's doctor noticed a "little Southern lady's cough," so he ordered a chest X-ray.
Within a week, Dawson got the dreaded diagnosis: Massive spots on her lungs, which meant late-stage lung cancer, one of the most fatal kinds.
The doctors told her it was too late to operate. So Dawson went through six months of chemotherapy instead, leaving her sick and weak. She couldn't work. She couldn't play with her grandchildren. She couldn't make quilts with her wool-spinning club.
"I prepared myself to die," Dawson later told an Atlanta newspaper.
With only six months to live, Dawson —- who doesn't smoke —- divided her diamonds and fine china among her two adult children.
But then... Dawson's misfortune quickly turned into a modern medical miracle...
As a last resort, doctors tried a radical new technology known as the "SNiP Technique."
It was Meredith Dawson's last hope...
Now, two years later, she's essentially cured.
Today, Dawson still works as a Publix floral arranger, and tests show her lungs are nearly clear. "I'm still here," she says proudly.
You can probably see why the "SNiP Technique" is creating such a stir among cancer doctors...
| • | Dr. Jo Anne Zujewski, head of breast cancer therapeutics at the government's National Cancer Institute, states: "In 1991, I didn't know that we would cure breast cancer... I'm convinced we have." |
| • | "Cancer is going to be like pneumonia," said Paul Bunn, president of the American Society of Clinical Oncologists, the nation's largest group of cancer doctors. "It won't be gone, but it will be controllable. . . . chemotherapy will be a thing of the past." |
Please keep in mind: Fighting cancer is just ONE APPLICATION of this miraculous new technology.
It's also being used to treat high blood pressure and to fight heart disease, leukemia, strokes, diabetes, Alzheimer's, cystic fibrosis, and much more.
What is the "SNiP Technique" exactly? And how does it work? Let me explain...
take a regular drug again
The concept underlying the "SNiP Technique" is pretty simple.
As you probably know, in every cell of our body, we have tiny sections of DNA called "genes."
These genes control every bodily function—every heartbeat, breath, muscle contraction, digestion, and immune response.
As humans, 99.9 percent of our genes are exactly the same as everyone else's. But the 0.1% variation makes a big, big difference.
This variation—where your DNA differs from someone else's DNA—is called a SNiP... a single nucleotide polymorphism.
Don't worry, the scientific name is not important... what is important is that SNiPs explain why some people are fat, while others are skinny. Why some people have brown eyes and others blue. Why some are great musicians... and others can run a 6-minute mile.
"And," says Dr. Elliott Sigal, vice-president of one of the nation's biggest healthcare companies, "this small amount of information holds clues to why people respond differently to medicine or are susceptible to disease."
In other words, scientists are discovering that your genes (more than anything else such as diet, exercise, or habits) determine whether or not you get sick, and how you respond to medication. For example...
| • | Imagine being able to learn about a heart attack before it occurs, so you could begin preventative treatment. A company called Cogenics has developed a simple genetic test that shows whether or not you have the gene that makes you susceptible to dysrrhythmia (an irregular heartbeat), which often leads to sudden cardiac death. |
| • | Researchers at a Salt Lake City, Utah company found a gene that determines whether or not salt will raise your blood pressure. If you've got the "good salt gene," you can eat all the salt you want. If not, you should be on a low-sodium diet. |
| • | 2 million Americans a day take blood-thinning heart drugs, which a recent New England Journal of Medicine study showed can cause deadly bleeding in patients with a unique genetic mutation. Wouldn't you want to know if you or someone you love has this dangerous gene? |
And these discoveries are just the tip of the iceberg...
Doctors and scientists have identified other genetic variations that can let you know if you're likely to get cancer, cardiovascular disease, Alzheimer's, cystic fibrosis, melanoma, hemophilia, liver disease, Muscular Dystrophy, Parkinsons, or Huntington's disease, just to name a few.
Doctors have known about these genetic variations for more than a decade.
But until recently, there was no way to test for these mutations BEFORE they caused problems. And there was no way to know how YOUR individual genes would affect your treatment or therapy.
Well, all of that's changing... and fast, thanks to the "SNiP Technique"...
How to make 1,943% with
the SNiP Technique
Most people don't know it, but doctors can now diagnose many diseases very early in their progression, simply by looking at your genes and biomarkers.
And they can even tell, simply by running a few tests, which diseases you are likely to get in the future.
As The Economist recently wrote: "you will not have to spend hours in a doctor's office to complete a comprehensive health check-up. Instead, with just a single pin-prick... based on this ‘molecular fingerprint,' your doctor will prescribe drug regimens tailored to your personal state of health that will not only be able to reverse many diseases, but will also prevent their manifestation in the first place."
The "SNiP Technique" encompasses a slew of new diagnostic devices, drugs, and therapies—all of which test and treat you as an individual—based on your specific genetic makeup and biomarkers.
This technology might sound space-age—and it was, just a few years ago.
But today—in 2007 — the "SNiP Technique" is a real and valuable new medical technology, both to patients with potentially life-threatening disorders, and to investors able to recognize the immediate profit potential in this new medical breakthrough.
You see, the truth is, these breakthroughs are already taking place in the real world. And they are making investors rich...
| • | A San Diego Company called Illumina has developed a technology that scans the DNA of thousands of people to find the genes linked to cancer, asthma, autism and other conditions. The company's share price has shot up 1,943%. |
| • | A company called Immucor sells equipment that tests for all kinds of diseases and ailments, just by looking at an ordinary blood sample. These machines are now used all over the world in hospitals, clinics, and doctor's offices. As a result, the company's shares have shot up 604%. |
| • | A company called Dade Bearing Holdings has developed some of the best genetic and protein diagnostic equipment. Since the company went public, the stock has shot up about 354%. |
| • | After a company called Affymetrix developed its "GeneChip" system to analyze complex genetic information, the company's share price shot up 2,315%. |
As you can see, the companies that are finding the best applications of the SNiP Technique are making a lot of money, very quickly.
|
And these SNiP Technique applications listed above are just the beginning...
The Journal of Clinical Oncology reports that researchers have identified a common genetic variant that explains why some women with breast cancer are more likely to relapse. Just a few days ago, scientists published a study in the journal Nature, reporting they've identified the two genetic variations most associated with developing diabetes.
In short, the "SNiP Technique," which is essentially the diagnosis and treatment of diseases based on your individual genetic makeup, has become the hottest and most important development in the medical world.
That's why hundreds of millions of dollars are pouring in to advance the "SNiP Technique." (See the sidebar to the right for more details.)
The bottom line is this: If you own the companies that have figured out the smartest and most valuable ways of applying the SNiP Technique to American Healthcare... then you stand to make a fortune over the next few years.
And here are the companies you should know about, and own, right away...
The 2 best SNiP Technique
investments right now
I recently hired two of the smartest and most well-connected guys in the medical industry.
In the past year they've each logged about 50,000 miles around the country, in search of the best investments in this field.
Rob Fannon has an MBA and a Masters in Public Health from Johns Hopkins. He worked in the Comprehensive Prostate Cancer Research Program at Cedars-Sinai Mecical Center in Los Angeles and also at a biotech firm outside of DC (he also helped the firm set up a division in Hyberadad, India).
Rob Fannon's assistant, Dr. George Huang, has a PhD in Biochemistry. Dr. Huang worked at a biotech firm in Canada, speaks three languages, and has been published in the four best scientific journals in his field.
These guys know their stuff.
They've each spent hundreds of hours in the lab doing genotype and gene sequencing work… performing immunoassays… performing all kinds of protein tests such as the Bradford assay… using Spectroscopy for chemical analysis… replicating DNA without live organisms… the list goes on and on.
They've presented work at scientific conferences around the country… have contracted with the National Institutes of Health (NIH) for follow-up work to the Human Genome project… and have worked side-by-side with Nobel Prize-winning scientists and doctors at the best universities and hospitals in the country, just to name a few.After 8 months of research, Rob Fannon and Dr. Huang tell me there are 6 SNiP Technique companies worth owning right now. They say you should buy 2 of these companies immediately.
Here they are...
| • | SNiP Technique Investment #1 is the best diagnostic company in America. Right now, the company has simple tests that screen for leukemia, colon cancer, and whether or not you are susceptible to a heart attack, arthritis, and liver disease. |
What we love about this company is that in addition to the cutting edge SNiP Diagnostics, they also conduct millions of other routine tests (like tests for drugs, sexually transmitted diseases, cholesterol, pregnancy, and diabetes), which makes them very profitable.
In fact, the company performs 500,000 tests each night, and makes results available the next day. They serve 50% of the doctors and hospitals in America.
The company's income has gone up by about $100 million, every year since 2000. So it's no surprise that investors are getting rich at the same time, earning 584% during that period. This is a company to buy right away, and hold for the next decade.
| • | SNiP Technique Investment #2 is a small company that has developed products to test for micro-organisms that cause a range of ailments, including tuberculosis, strep throat, pneumonia and sexually transmitted diseases. |
Also, the company has developed tests for HIV, hepatitis C, and the West Nile Virus in our nation's blood supply, so you don't contract one of these ailments as part of a blood transfusion.
In fact, this work is so important that in Nov. 2005, President Bush gave this company the National Medal of Technology—our country's highest honor for technological innovation. Prior winners include DuPont, IBM, Johnson & Johnson, Merck, and 3M.
Since 2003 this stock has been on a straight climb higher... up about 330% during that time. We believe those gains are only the beginning.
Rob Fannon and Dr. Huang have just finished a Research Report with all of their findings. It's called: The Doctor's Retirement Package—How the SNiP Technique can Make you a Fortune Over the Next 5 Years.
We call this Research Report the Doctor's Retirement Package because for the most part, the only people who know about this great investment and are capitalizing on it right now, are doctors and scientists.
As you'll see, this Report covers a group of the best SNiP technology companies in the world. If you buy these companies today, it's possible you could make enough to retire on in the next few years. That's what many doctors are doing. We recommend you do the same.
In this Research Report, you'll learn where the "SNiP Technique" stands today, and where it's going in the near future. And you'll learn exactly which investments stand to make you the most money over the next few years.
You'll get the complete details on the 2 investments I just mentioned, which we recommend you make right away.
You'll also get the details on 4 other SNiP Technique companies we expect to recommend in the coming months.
One of these companies has developed genetic tests for certain cancers and even Alzheimer's. Another has developed tests for bacteria disorders (such as gastrointestinal and respiratory diseases). The third company has the best genetic testing equipment in the world, which is used by every serious research institution. The fourth company has developed revolutionary tests for heart attacks and cardiovascular disease.
Several of these companies are scheduled to launch new SNiP Technologies in the coming months. Others are awaiting final clinical trials. You'll learn everything you need to know inThe Doctor's Retirement Package.
I'd like to send you this Research right away—and free of charge. I believe the sooner you invest, the more money you will make.
How can you get your free copy? Let me show you...
How to make 500% over
the next two years
My name is George Rayburn.
I'm the Publisher of a Baltimore-based firm called Stansberry & Associates Investment Research.
We started this business a little more than six years ago—and have already become one of the top-3 independent Investment Research firms in America, in terms of size and numbers of subscribers.
The secret to our growth and success is that we hire the best investment analysts in the country—former Certified Financial Planners, stockbrokers, mutual fund managers, hedge fund mangers, bond traders, geologists, chemists, medical doctors, MBAs, etc.
Just this month, for example, one of my PhD analysts traveled to Japan. One is in Florida. Another has gone to Oregon. Two others went to California. And two others are off to Switzerland. All in search of great investment ideas, which we share with our paid subscribers.
Our analysts have been profiled in Barron's, The Wall Street Journal, and more than a dozen other publications. But what we're most proud of is how we've helped many people change their lives, by showing them how to safely make more money than they ever imagined possible.
| • | For example, a subscriber named Jack Marks, from Pittsburgh, wrote to tell us he made 340% on a recent recommendation. He added: "I suppose... a house in Hilton Head may still be in the cards for me." |
| • | A subscriber named Clyde Lafond, 68, from Burbank, CA, wrote to tell us: "My $600,000 is now worth well over a $1,000,000. I think that I am almost ready to retire." |
| • | A subscriber and retired cardiac surgeon named R. C. Beck recently told us: "I took my wife's portfolio from her advisor and quadrupled it." |
Right now, we believe some of the absolute best investment opportunities in the world right now are in healthcare and medicine.
That's why, about a year ago, I hired Rob Fannon and Dr. Huang—two of the most well-connected healthcare insiders in the country.
I brought these guys on to investigate medical and healthcare investment opportunities, and then to share their insights with our readers in a monthly publication called The Medical Investor. In the past year they've visited more than a dozen companies in person, and have attended the healthcare industry's biggest events (I'll give you more details in a minute).
One of the opportunities Rob Fannon and Dr. Huang are most excited about right now is the "The SNiP Technique." That's why I'd like to send you, free of charge,The Doctor's Retirement Package Research Report they've prepared.
I believe these investments give you a very good chance to make 500% or more over the next few years. I know that's a big promise, but several companies involved in this new medical practice have already returned twice that much... and this health care breakthrough is really just getting started.
In exchange for receiving this Research Report free of charge, all I ask is that you try a no-risk trial subscription to Rob Fannon's and Dr. Huang's research—The Medical Investor—our newest and most-exciting publication.
I'll tell you more about these guys and The Medical Investor in a minute.
But first, let me tell you about another great investment opportunity Rob Fannon and Dr. Huang have uncovered in their recent travels...
The hidden secrets of
America's healthcare fortune
Did you know that 16 cents of every dollar made in America goes to healthcare? Incredible.
But if you're like me, you've probably wondered... where does all of this money go?
Well, a lot of it goes to doctors, hospitals, and drug and insurance companies. That's no surprise.
But what most Americans don't know is that a handful of secret medical businesses you've probably never heard of get the rest. We call these companies "The hidden secrets of America's healthcare fortune."
For example...
Did you know that every time someone in a nursing home takes a pill, chances are good that a Kentucky business called Omnicare Inc. makes a profit?
It's like a nationwide drugstore for nursing homes — and a very profitable one, because Omnicare's contracts include roughly half the nursing home beds in the country.
If you knew this hidden secret of the healthcare world, you could have made 409% in a four-year span... and 1,995% over roughly the past 16 years.
The point is, these "hidden secrets" in the health care world are companies you won't read about on the front page of The Wall Street Journal. There's nothing sexy about what they do...
Except that they make incredible profits for shareholders.
The only way you're going to hear about these secret opportunities is through a reliable industry insider...
That's why I hired Rob Fannon and Dr. Huang, who recently told me about the best "hidden secret" in the healthcare field right now, which you can profit from beginning immediately...
The most profitable healthcare
Secret in America
Did you know that when a biotech or pharmaceutical company wants to test a new drug, they usually hire an outside company to perform the actual tests?
These testing firms are middlemen who find doctors, recruit patients, and compile the data.
What's great is, these testing firms make huge profits, whether a drug passes or fails its test!
Imagine if you could make money on every drug that's tested, whether it passes or fails. That's essentially what these testing companies do. It's low risk... and high reward for owners and shareholders.
The way I look at it is, let other people gamble on whether or not a new drug will succeed or fail... I'd rather take the sure thing and get paid every time a drug is tested.
|
What's exciting is that there are two companies dominating this business in America.
One of these companies specializes in the Early-Stage Tests (Phases 1 and 2) of new drugs. The other specializes in Late-Stage tests (Phase 3).
And get this: These companies test the majority of new drugs. Their net revenues have each increased by about $100 million for five straight years.
So it's no surprise that these companies are virtual cash machines for shareholders. One company has returned 470% gains since the beginning of 2000. The other has returned about 150% since the beginning of 2004.
If you want a simple and safe way to make a fortune over the next few years as more and more drugs get tested, this is the best way to do it.
There's no guarantee as to how many drugs will get approved each year—but there is a guarantee that every drug must pass full FDA tests before it can be sold. And the companies that provide these services will keep profiting exponentially.
Barron's reports that: "Demand [for these testing services] is on the rise. More drugs are now in development and need testing, and big drug makers, including Pfizer and Johnson & Johnson are outsourcing development-related work to cut costs and speed along drug approvals."
One of the companies I'm going to tell you about has a $2.24 billion-dollar backlog of business—a 24% increase from the year before. The other company has a backlog of $2.2 billion worth of business, a 33% increase from the year before.
The point is, these companies are growing moneymaking machines—and offer you a super-safe way to make outstanding returns for the next few years.
Rob Fannon and Dr. George Huang have written a special Research Report to help you take advantage of this situation immediately. It's called: The Big Hidden Secret of America's Healthcare Fortune. When you take a trial subscription to The Medical Investor, you'll receive a copy of this new Report, free of charge.
How will you know if The Medical Investor is right for you?
Let me explain why we started it, which should help you decide whether or not to give it a try...
Where the money is going
in America right now
I'm not sure if you are aware of this or not, but healthcare is by far the fastest-growing industry in the U.S. ...
A recent BusinessWeek article detailed how, since 2001, 1.7 million new jobs have been added to the healthcare sector. Guess how many jobs have been added in the rest of the economy? Zero. As the magazine reported: "Healthcare has become the main American job program for the 21st century."
The Department of Labor projects a 30.3% increase in the number of healthcare jobs between now and 2014. That's 4.7 million new healthcare jobs!
Why is this happening?
One of the biggest reasons is because almost every major city in the country is pouring millions into new biotech businesses, medical research facilities, and high-tech hospitals:
- Philadelphia is spending $1.7 billion to expand its leading pediatric center, and is adding a $1.2 million research facility. A Philadelphia hospital administrator says: "Healthcare is the major engine for the economy of the city of Philadelphia."
- California will pour $3 billion into biotech research over the next 10 years.
- Cleveland has formed a group called Bioenterprise, a consortium of hospitals, universities, and healthcare companies to attract grants and business to the area. So far they've attracted more than $300 million in funding.
- Baltimore "is uniquely poised to become the Silicon Valley of biotech," reports The Sun, the city's biggest newspaper.
- The Chicago Tribune reports their city "is ripe to become a biotech powerhouse... "
The point is... U.S. healthcare is where the money is right now... and where the money will keep going for the next 5 years at least.
It's also one of the best places for investors to make big returns...
For example, did you know that 3 of the top 5 investments over the past six months were in the healthcare field?
| • | One of these companies, called Carematrix Corp, which provides assisted living to seniors, returned well over 5,000% during the last 6 months. The other two top healthcare returners provided gains of well over 1,000% apiece, during the same time. |
The long-term numbers are even better...
Since 1973, healthcare stocks (measured by the Datastream Healthcare Index) have beaten the stock market in general (as measured by the S&P 500 Index), by a whopping 875%!
|
As Liu-Er Chen, a manager at Evergreen Funds in Boston, says: "Over the past 10 or 15 years, healthcare stocks have significantly outperformed the S&P 500, and the future long-term results should be similar or even better, for obvious reasons."
What are these "obvious" reasons?
Well, the biggest is the major demographic shift taking place in America right now: Baby Boomers are retiring, and they will spend much more money on medical care in the coming years than they ever have before.
As The New York Times recently reported: "Baby boomers are descending upon the healthcare infrastructure of the United States like locusts upon a cornfield.''
Again, healthcare is where the money is right now—and it's where the money is going over the next 5 years and beyond.
You can make a lot of money with the best healthcare investments, no matter what's happening with the rest of the economy or the stock market.
That's why, for the past year, we've been working on our newest investment research publication, The Medical Investor. Most of the investments we recommend will be in the United States, but Rob Fannon and Dr. Huang will also recommend great opportunities when they find them overseas.
We're publishing this research because we believe healthcare is the best place to make a lot of money in the coming years... and because, as the editors of Financial Planning recently wrote: "The healthcare sector is... relatively recession-proof. If people are sick and can afford healthcare, they won't skimp on it just because the market is down or the economy is weak."
That's why we've spent a fortune hiring the best analysts in the business...
Harvard doctor helps make
100% gains in one day
I mentioned earlier how Rob Fannon has an MBA and Masters in Public Health from Johns Hopkins University. How he's worked in the lab of one of America's best hospitals, and even helped set up a biotech firm in India.
I also described how Rob's Assistant, Dr. George Huang, has worked at biotech firms and top universities in the U.S. in Canada.
What I didn't tell you is how good these guys are at using their inside contacts to find great investments...
| • | From his work in genetics, Rob told us about a radical new medical treatment called RNAi, which is being used to treat several major disorders. After consulting with Dr. Judy Lieberman — a Professor of Medicine at Harvard University... and a patent attorney, Rob added an RNAi company called Sirna to his portfolio. Just 6 months later, it was bought out by Merck — and the stock DOUBLED OVERNIGHT. Those who got in at our original recommendation, made 203% gains. Rob added another RNAi company called Alnylam Pharmaceuticals (ALNY) to the portfolio. So far the stock is up 43%... with a long way to go. |
| • | Likewise, Rob's connections with world-famous heart doctor P.K. Shah at Cedars-Sinai Hospital led us to recommend a company called Esperion, which developed a new way to treat heart disease. Rob worked in a lab down the hall from Shah, who was involved in early research that went into the company. Three weeks after we recommended Esperion, the stock jumped 55% overnight, when is was bought by Pfizer. |
| • | Rob used his connections at Johns Hopkins to learn about a new vaccine technology called PER.C6, which is being licensed by dozens of big companies. In fact, Rob even set up a meeting between the company behind it (called Crucell) and the university. Since we recommended Crucell, our readers have had the chance to make gains of 292% |
Keep in mind, Rob Fannon has only been with our firm as a full-time analyst for one year. In that short time he and Dr. Huang have visited health care and medical companies in North Carolina, San Francisco, Vancouver, San Diego, Boston, Atlanta, Baltimore, and New York.
They've been to all of the indutry's big meetings: The Biotechnology Industry Organization conference in Philly... the American Association of Cancer Research conferences in D.C., San Fran., and Orlando... the Experimental Biology Conference in San Francisco... the American Society of Hematologists Conference in Orlando.
Plus they've been to specialized medical meetings such as the American Association for the Study of Liver Diseases in Boston... and they'll soon be traveling to the American Society for Clinical Oncology conference in Chicago.
If you were in my position, wouldn't you have hired them too?
They're smart, well-connected, and work hard to find the best investments in medicine and healthcare.
What I also like about Rob Fannon and Dr. Huang is that they are scientists, not stock promoters. So they're both extremely skeptical and conservative.
Every recommendation they make will offer you a conservative way to take advantage of the boom in the healthcare industry.
That's one of the reasons why, already, in the limited research Rob Fannon and Dr. Huang have done in the past year, the response from our readers has been incredible...
| "In 30 years of subscribing to advisories, [Rob Fannon's] is by far the best in my judgment. My portfolio has a $32,487 profit in less than 6 months." |
- Jack Milligan, Memphis, TN |
| "Your service is without a doubt the best I have used. In fact, I have eliminated all the others. Keep up the good work!" |
- Gerald Sinclair, Delray Beach, FL |
| "In 6 months, I am already up 82.3%... 42.3%... and 40.8% on your recommendations. Your team is doing a great job. I am learning more than I expected... especially opportunities that I would otherwise never hear about. I am very happy..." |
- Steven Stockton, Henderson, NV |
| "In 2 ½ months, I have already made a 125.3% gain... easily the best-performing newsletter among the many that I'm subscribed to." |
- Sam Quincey, Santa Cruz, CA |
We believe the past year has been a great test for Rob Fannon and Dr. Huang.
That's why we are excited to invite you to become a charter subscriber to their brand-new service, called The Medical Investor. In fact, look at a few of the other moneymaking opportunities these guys are looking at right now...
● The only legal monopoly in America. Did you know that the only legal monopoly you can have in America is in a specific sector of the healthcare field? Thanks to the U.S. government, a handful of companies have used this law to secure stock market gains of more than 1,300%. In The Medical Investor, you'll learn about this legal monopoly, and how you can use it to make a fortune in the coming years.
● The only drug company you need to own. There's one drug company that is head and shoulders above the rest—it's one of the biggest and most profitable makers of generic and brand-name drugs. Surprisingly, you've probably never heard of it before. This company has been going steadily up for the past 5 years, with gains of almost 100%. You can buy it today, forget about it for the next decade, and make a lot of money in dividends and capital gains.
In fact, Rob Fannon and Dr. Huang just recommended this company in their Feb. 2007 issue of The Medical Investor. You'll have instant access to this report as soon as you subscribe.
Of course, these opportunities to make safe profits in the health care sector are just the beginning.
When you take a no-risk-trial subscription to The Medical Investor, you will receive:
| • | Every month, Rob Fannon and Dr. George Huang will send you a full report on their best healthcare investment idea. You'll receive this Report by e-mail at approximately 6pm, on the 2nd Wednesday of every month. |
| • | Investment Report: The Doctor's Retirement Package—How the SNiP Technique can Make you a Fortune Over the Next 5 Years. In short, there's a revolutionary technology in the process of changing the entire healthcare industry. In this report you'll learn about the 2 best companies to buy right away, and the 4 companies we'll be recommending in the coming months to capitalize on this major trend. |
| • | Investment Report: The Big Hidden Secret of America's Healthcare Fortune. There's a secret way to make several times your money over the next few years, in a little-known health business that is making investors a fortune. |
| • | E-mail Updates. When you take a subscription to The Medical Investor, you'll also receive daily e-mail updates on what Rob Fannon, Dr. Huang, and the 8 other analysts in our business are pursuing. |
Keep in mind that when you sign up to take a risk-free trial subscription to The Medical Investor, you will have the next six (6) months to decide if it's right for you.
We want you to be happy with our work. And there's no sense doing business together if you're not. That's why you can try The Medical Investor for the next six months at no risk. If you're not happy for any reason, you can get a full refund.
So how much does it cost to receive The Medical Investor and everything else mentioned here?
I think $1,000 per year is a fair price, based on the value of this work, and the cost of putting it together. Rob Fannon and Dr. Huang have charged as much as $5,000 a year for their work.
But right now we are temporarily offering Rob Fannon's and Dr. Huang's Research for significantly less.
Before I give you the details... let me tell you about one more thing you'll receive with your subscription.
It's the full details on what could easily be the most profitable stock in the market over the next 12 months...
How to make 619% in 2 years
Investing in new medical devices is one of the best ways to get rich in the stock market. (See the sidebar below for a few examples of what I mean.)
That's why Rob Fannon and Dr. George Huang are so excited about a tiny company that has developed a radically new and totally safe way of taking pictures inside of your body.
|
It's safer than X-Rays, MRIs, or CAT Scans, and is already approved by the FDA. So far, this new technology has been used on 450,000 patients worldwide, with amazing results for certain cancers and many gastrointestinal problems...
| • | When a patient named Matthew Anci was treated with the device, he said: "It changed my life completely. It really did save my life... " |
The small company behind this new invention has 43 patents in the United States, Europe, Japan, Australia, and elsewhere around the world. Their new invention has been profiled in Nature, the most important journal in the medical industry, three times (volumes: 405, 417, and 438).
Still, the company is almost completely unknown, despite the fact that the share price has already started to climb... up about 25% since last summer.
Even better, this tiny company has a $50 million marketing deal with Johnson & Johnson, the biggest medical device company in the world.
Unfortunately, I can't be any more specific here. What I can say is that I believe you will be shocked when you see how radical this new device is. I was so impressed I had one of my researchers contact the company to see which doctors in my area are using it. Turns out there are 22 nearby, including doctors at Georgetown Medical Center, Sinai Hospital in Baltimore, and Johns Hopkins Hospital.
When you subscribe to The Medical Investor, you'll be among the first to get all the details, when Rob Fannon and Dr. Huang send you their latest report, called: The Most Profitable New Medical Device Investment in the World Right Now.
This Research Report, like everything else I've described in this letter, is free with your trial subscription to The Medical Investor.
As I mentioned, Rob Fannon and Dr. Huang charge as much as $5,000 for their research.
Right now, we're charging Charter Subscribers just $199 for a year of The Medical Investor, including everything I mentioned in this letter. We will soon begin charging considerably more than this introductory rate.
When you see the amount of work Rob Fannon and Dr. Huang do on every recommendation they make... and the investment gains that pile up every single month, I think you may agree with me that this is the most under-priced investment research in the country.
To get started right away Subscribe Now
By ordering now you will have on-line access to everything described here in the next 15 minutes.
Sincerely,
George Rayburn
Publisher, The Medical Investor
P.S. I don't know if you saw it or not, but there was a big story about the "SNiP Technique" in the Business section of The New York Times Sunday edition, about a week ago. Word on this breakthrough is getting out. I encourage you to act prudently, but quickly, to make the most of this opportunity.